Magnetic Surgery System Tested Successfully On First Patient

December 22, 1998

ST. LOUIS, Mo., December 22, 1998 -- A revolutionary system that uses superconducting magnets and advanced computer imaging technology to automatically navigate a catheter through the brain was tested successfully on the first patient last Thursday at Barnes-Jewish Hospital in St. Louis.

The system, approved for use under a U.S. Food and Drug Administration (FDA) Investigational Device Exemption, is being evaluated as a potentially safer, less invasive, and more effective way to biopsy brain tumors. Future applications under development include diagnosing and treating cardiovascular conditions, such as coronary artery disease and cardiac arrhythmias, and treating neurovascular conditions such as aneurysms. The system was developed by Stereotaxis, Inc., a St. Louis-based company in the field of image-guided interventional medicine.

"Our new system fulfills a growing need for more efficient, cost-effective surgical techniques," said Bevil J. Hogg, president and chief executive officer of Stereotaxis. "While our initial focus has been on neurosurgical applications, we believe this system has the potential to be used in many cardiovascular and neurovascular procedures, as well." The first patient to undergo the procedure, a 31-year-old man, was diagnosed with a tumor in the frontal lobe of the brain. In all, five patients will participate in the first clinical trial of the Magnetic Surgery System at Barnes-Jewish Hospital.

The Magnetic Surgery System may prove to be a significant improvement over current stereotactic surgery. Presently, surgeons visualize the location of a brain tumor through MRI imaging technology, but must manually guide surgical instruments on a straight-line path to the target location, possibly passing through and damaging vital brain tissue.

"This new system is a fundamentally new approach to guiding surgical instruments during brain surgery," explained Dr. Ralph G. Dacey, professor and chairman of the Department of Neurological Surgery at Washington University School of Medicine in St. Louis and principal investigator of the trial. "Not only does this system allow us to follow a curved path through the brain, but for the first time a computer is able to steer a catheter using externally applied magnetic fields acting on the catheter tip, giving us greater navigational control."

Michael Lawson, program manager for intracerebral applications at Stereotaxis, explained that a thin, flexible guidewire which is tipped with a magnetic seed slightly larger than a grain of rice fits into a catheter. After inserting the guidewire and catheter into a small hole in the skull, the surgeon the uses the computer's mouse to chart a path for the catheter on a preoperative MRI image, avoiding important areas of the brain. The computer changes the magnetic field of the superconducting magnets that surround the patient's head, guiding the catheter along the predetermined curvilinear path through the brain.

The computer recalculates the position and the trajectory of the catheter every millimeter it travels. The entire navigation process takes less than 5 minutes. Once the catheter reaches the lesion, the guidewire is withdrawn, leaving the catheter in place. A highly flexible biopsy tool is inserted, the biopsy is taken and the catheter is removed.

"Our Magnetic Surgery System represents the first true interventional workstation, integrating magnets, computers and medical imaging. This combination allows for the direct distal-tip control of catheters which we believe will improve a clinician's ability to access remote areas of the body, improving diagnostic accuracy and treatment outcomes," said Hogg. "This clinical trial is an important step in demonstrating the effectiveness of this new model of interventional medicine."

Following the first clinical trial of the magnetic surgery system, Stereotaxis will submit the results to the FDA. The company will then seek the agency's approval to conduct a second clinical trial involving frontal lobe biopsies in a larger group of patients. After the second clinical trial, the company will seek FDA approval to commercialize the system.

Stereotaxis (http://www.stereotaxis.com) was founded in 1990 to further develop the pioneering work of several researchers at the University of Virginia, the University of Iowa, and the University of Washington in magnetic instrument guidance. The company is funded by a number of venture capital firms including Alafi Capital Company, CID Equity Partners, Graystone Venture Partners and Sanderling Ventures. Local St. Louis investors include Advantage Capital Partners, A.G. Edwards, BJC Health System, Community Investment Partners, Emerson Electric, Gateway Venture Partners, and Oakwood Investors.
-end-
Contact:
Tim Carley / 314-982-0263
Ellen Rostand / 314-982-9133

Press briefing scheduled for 11 a.m., Tuesday, December 22, in the Magnetic Surgery Suite, Barnes-Jewish Hospital.

Editor's Note: Press kit with fact sheet and camera-ready photographs are available upon request.
Electronic images are available as well



Fleishman-Hillard, Inc.

Related Brain Articles from Brightsurf:

Glioblastoma nanomedicine crosses into brain in mice, eradicates recurring brain cancer
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

Children with asymptomatic brain bleeds as newborns show normal brain development at age 2
A study by UNC researchers finds that neurodevelopmental scores and gray matter volumes at age two years did not differ between children who had MRI-confirmed asymptomatic subdural hemorrhages when they were neonates, compared to children with no history of subdural hemorrhage.

New model of human brain 'conversations' could inform research on brain disease, cognition
A team of Indiana University neuroscientists has built a new model of human brain networks that sheds light on how the brain functions.

Human brain size gene triggers bigger brain in monkeys
Dresden and Japanese researchers show that a human-specific gene causes a larger neocortex in the common marmoset, a non-human primate.

Unique insight into development of the human brain: Model of the early embryonic brain
Stem cell researchers from the University of Copenhagen have designed a model of an early embryonic brain.

An optical brain-to-brain interface supports information exchange for locomotion control
Chinese researchers established an optical BtBI that supports rapid information transmission for precise locomotion control, thus providing a proof-of-principle demonstration of fast BtBI for real-time behavioral control.

Transplanting human nerve cells into a mouse brain reveals how they wire into brain circuits
A team of researchers led by Pierre Vanderhaeghen and Vincent Bonin (VIB-KU Leuven, Université libre de Bruxelles and NERF) showed how human nerve cells can develop at their own pace, and form highly precise connections with the surrounding mouse brain cells.

Brain scans reveal how the human brain compensates when one hemisphere is removed
Researchers studying six adults who had one of their brain hemispheres removed during childhood to reduce epileptic seizures found that the remaining half of the brain formed unusually strong connections between different functional brain networks, which potentially help the body to function as if the brain were intact.

Alcohol byproduct contributes to brain chemistry changes in specific brain regions
Study of mouse models provides clear implications for new targets to treat alcohol use disorder and fetal alcohol syndrome.

Scientists predict the areas of the brain to stimulate transitions between different brain states
Using a computer model of the brain, Gustavo Deco, director of the Center for Brain and Cognition, and Josephine Cruzat, a member of his team, together with a group of international collaborators, have developed an innovative method published in Proceedings of the National Academy of Sciences on Sept.

Read More: Brain News and Brain Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.